Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2006 1
2009 1
2011 1
2012 2
2013 2
2014 3
2016 2
2017 2
2020 1
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study.
Ghelani GH, Zerdan MB, Jacob J, Spiess PE, Li R, Necchi A, Grivas P, Kamat A, Danziger N, Lin D, Huang R, Decker B, Sokol ES, Cheng L, Pavlick D, Ross JS, Bratslavsky G, Basnet A. Ghelani GH, et al. Urol Oncol. 2023 Dec;41(12):486.e15-486.e23. doi: 10.1016/j.urolonc.2023.09.001. Epub 2023 Oct 9. Urol Oncol. 2023. PMID: 37821306 Free article.
BACKGROUND: Advanced bladder squamous cell carcinoma (aBSCC) is an uncommon form of urinary bladder malignancy when compared with the much higher urothelial carcinoma incidence. ...
BACKGROUND: Advanced bladder squamous cell carcinoma (aBSCC) is an uncommon form of urinary bladder malignancy w …
Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma.
Rausch S, Lotan Y, Youssef RF. Rausch S, et al. Urol Oncol. 2014 Jan;32(1):32.e11-6. doi: 10.1016/j.urolonc.2012.11.020. Epub 2013 Feb 20. Urol Oncol. 2014. PMID: 23433891 Review.
Bladder squamous cell carcinoma, squamous metaplasia, and transitional cell carcinoma with squamous differentiation are infrequent findings in Western countries. ...Our review summarizes the available data on clinical presentation, treatment, and outco …
Bladder squamous cell carcinoma, squamous metaplasia, and transitional cell carcinoma with squamous differentiat …
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
Necchi A, Madison R, Raggi D, Jacob JM, Bratslavsky G, Shapiro O, Elvin JA, Vergilio JA, Killian JK, Ngo N, Ramkissoon S, Severson E, Hemmerich AC, Huang R, Ali SM, Chung JH, Reddy P, Miller VA, Schrock AB, Gay LM, Alexander BM, Grivas P, Ross JS. Necchi A, et al. Eur Urol. 2020 Apr;77(4):548-556. doi: 10.1016/j.eururo.2020.01.003. Epub 2020 Jan 17. Eur Urol. 2020. PMID: 31959546
Bladder squamous cell carcinoma in situ in the background of condyloma acuminatum in a kidney transplant recipient.
Yan CL, Gallo RA, Pandiri M, Gallo SJ. Yan CL, et al. Can J Urol. 2023 Apr;30(2):11505-11508. Can J Urol. 2023. PMID: 37074751
Condyloma acuminatum with synchronous squamous cell carcinoma in situ (CIS) rarely occurs in the bladder. In developed countries, bladder squamous cell carcinoma (SCC) is uncommon. Among the various noninvasive squamous bladder lesions, there is signif …
Condyloma acuminatum with synchronous squamous cell carcinoma in situ (CIS) rarely occurs in the bladder. In developed countries, bladder …
Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder.
Youssef RF, Shariat SF, Kapur P, Kabbani W, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y. Youssef RF, et al. J Urol. 2011 Mar;185(3):1112-7. doi: 10.1016/j.juro.2010.10.036. Epub 2011 Jan 21. J Urol. 2011. PMID: 21255800
CONCLUSIONS: Cyclooxygenase-2 over expression is associated with pathological stage, grade and worse outcomes after radical cystectomy, suggesting a role in bladder squamous cell carcinoma progression. Our findings support the need for further evaluati …
CONCLUSIONS: Cyclooxygenase-2 over expression is associated with pathological stage, grade and worse outcomes after radical cystectomy, sugg …
High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.
Cowan M, Springer S, Nguyen D, Taheri D, Guner G, Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Bivalacqua TJ, Kinzler K, Vogelstein B, Netto GJ, Papadopoulos N. Cowan M, et al. Mod Pathol. 2016 May;29(5):511-5. doi: 10.1038/modpathol.2016.53. Epub 2016 Mar 11. Mod Pathol. 2016. PMID: 26965579 Free PMC article.
TERT promoter mutations, commonly found in conventional urothelial carcinoma, are also highly prevalent in urinary bladder squamous cell carcinoma suggesting a common tumorigenesis and potential utility as a molecular urine-based-screening assay....
TERT promoter mutations, commonly found in conventional urothelial carcinoma, are also highly prevalent in urinary bladder squamou …
21 results